<DOC>
	<DOCNO>NCT01578460</DOCNO>
	<brief_summary>Poor glucose control pregnancy significant concern Canadian woman diabetes . This problem magnify First Nations woman , among high rate gestational diabetes ( GDM ) world ( 18 % First Nations woman develop GDM pregnancy 70 % go develop type 2 diabetes later ) . Continuous glucose monitoring ( CGM ) technology potential help woman maintain tight control pregnancy , however , First Nations population , many unique barrier may affect use technology . Such barrier include remoteness community , cultural apprehension , lack difficulty access care , language difference . A total 60 participant three participate First Nations community Southern Ontario participate study . Participants self-select either CGM group ( n=30 ) control group ( n=30 ) consent participate study . Participants group ask monitor blood glucose 5 day 28th , 32nd 36th week gestation . Primary outcome evaluate include maternal A1c offspring birth weight . To assess feasibility acceptability CGMs among First Nations woman , questionnaire distribute participant gather insight rationale enrol either group . Recruitment rate group also use assess feasibility acceptability CGMs . Additionally , participant encourage participate community lifestyle program consist 30-min exercise session offer five day week . The community lifestyle program adapt community , link exist program support program personnel include educational session relate diabetes healthy lifestyle . It hypothesize participation community lifestyle program , pregnant First Nations woman diabetes experience decrease blood glucose value post-exercise , mitigate excessive weight gain normalize A1c 's . It hypothesize increase woman 's regular physical activity level , number step take knowledge diabetes observe .</brief_summary>
	<brief_title>Healthy Moms , Healthy Babies</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<criteria>First Nations ( selfidentified ) Onreserve ( live receive care ) Informed consent participate Adults age 18 year old Diagnosed gestational diabetes ( GDM ) type 2 diabetes ( T2DM ) Pregnant ( less equal 36 week gestation ) Consent primary care giver inform participation teh project Willingness perform require study data collectin procedure adhere operate requirement iPro2 and/or glucose meter Willingness wear iPro 2 continuous glucose monitor ( CGM ) 5 day 28th , 32nd , 36th week pregnancy ( participant CGM group ) Willingness perform least 4 finger prick test per day Monitoring Week 28th , 32nd , 36th week pregnancy ( CGM control group ) Lack decision making capacity provide consent Participating another diabetes and/or lifestyle improvement research project NonFirst Nations descent Pregnant diagnose type 1 diabetes Pregnant diagnose GDM T2DM Pregnant woman past 36th week gestation Participants consent primary care giver inform project participation The participant history tape allergies resolve The participant skin abnormality ( e.g . Psoriasis , rash , staphylococcus infection ) resolve would inhibit wear sensor Any condition ( ) Investigator 's opinion would warrant exclusion study prevent participant completing project</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pregnancy</keyword>
	<keyword>Gestational Diabetes</keyword>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Continuous Glucose Monitor</keyword>
	<keyword>Glucose</keyword>
</DOC>